{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:34:29Z","timestamp":1792424069134,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"DOI":"10.7759\/cureus.63307","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T21:08:50Z","timestamp":1719522530000},"source":"Crossref","is-referenced-by-count":4,"title":["Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: A Single-Centre Experience"],"prefix":"10.7759","author":[{"given":"B\u00e1lint","family":"Virga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Pincz\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Ill\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Milt\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Magyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"M\u00e9hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1556\/650.2015.30260","article-title":"[Novel treatment options in relapsed and refracter Hodgkin lymphomas]","volume":"156","author":"Ill\u00e9s \u00c1","year":"2015","unstructured":"Ill\u00e9s \u00c1, J\u00f3na \u00c1, Simon Z, Udvardy M, Milt\u00e9nyi Z. [Novel treatment options in relapsed and refracter Hodgkin lymphomas]. Orv Hetil. 2015, 156:1824-33. 10.1556\/650.2015.30260","journal-title":"Orv Hetil"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf146","article-title":"World Health Organization classification of tumours: pathology and genetics of Tumours of Haematopoietic and lymphoid tissues","volume":"13","author":"Hossfeld DK","year":"2002","unstructured":"Hossfeld DK. World Health Organization classification of tumours: pathology and genetics of Tumours of Haematopoietic and lymphoid tissues. Ann Oncol. 2002, 13:71-95. 10.1093\/annonc\/mdf146","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01764-1","article-title":"A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas","volume":"37","author":"Falini B","year":"2023","unstructured":"Falini B, Martino G, Lazzi S. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. Leukemia. 2023, 37:18-34. 10.1038\/s41375-022-01764-1","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<510:: AID-IJC2>3.0.CO;2-X","article-title":"Patients suffering from both Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients","volume":"71","author":"Amini RM","year":"1997","unstructured":"Amini RM, Enblad G, Sundstr\u00f6m C, Glimelius B. Patients suffering from both Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int J Cancer Res. 1997, 71:510-6. 10.1002\/(SICI)1097-0215(19970516)71:4&lt;510:: AID-IJC2&gt;3.0.CO;2-X","journal-title":"Int J Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.625529","article-title":"Transition between diffuse large B-cell lymphoma and classical Hodgkin lymphoma-our histopathological and clinical experience with patients with intermediate lymphoma","volume":"27","author":"Simon Z","year":"2021","unstructured":"Simon Z, Virga B, Pincz\u00e9s L, et al.. Transition between diffuse large B-cell lymphoma and classical Hodgkin lymphoma-our histopathological and clinical experience with patients with intermediate lymphoma. Pathol Oncol Res. 2021, 27:625529. 10.3389\/pore.2021.625529","journal-title":"Pathol Oncol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9810-x","article-title":"Histopathological difficulties in an adolescent lymphoma patient","volume":"21","author":"Magyari F","year":"2015","unstructured":"Magyari F, Barna S, Milt\u00e9nyi Z, et al.. Histopathological difficulties in an adolescent lymphoma patient. Pathol Oncol Res. 2015, 21:213-7. 10.1007\/s12253-014-9810-x","journal-title":"Pathol Oncol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/5.suppl_1.s7","article-title":"The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas","volume":"5 Suppl 1","author":"Jaffe ES","year":"1994","unstructured":"Jaffe ES, Zarate-Osorno A, Kingma DW, Raffeld M, Medeiros LJ. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol. 1994, 5 Suppl 1:7-11. 10.1093\/annonc\/5.suppl_1.s7","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904223401604","article-title":"Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma","volume":"340","author":"Br\u00e4uninger A","year":"1999","unstructured":"Br\u00e4uninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K, K\u00fcppers R. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999, 340:1239-47. 10.1056\/NEJM199904223401604","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17327","article-title":"Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"193","author":"Eichenauer DA","year":"2021","unstructured":"Eichenauer DA, M\u00fcller H, Elger L, et al.. Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br J Haematol. 2021, 193:515-9. 10.1111\/bjh.17327","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld M","year":"2015","unstructured":"Schaapveld M, Aleman BM, van Eggermond AM, et al.. Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma. N Engl J Med. 2015, 373:2499-511. 10.1056\/NEJMoa1505949","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28194","article-title":"Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors","volume":"119","author":"Xavier AC","year":"2013","unstructured":"Xavier AC, Armeson KE, Hill EG, Costa LJ. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors. Cancer. 2013, 119:3385-92. 10.1002\/cncr.28194","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12040963","article-title":"The need for standardization in next-generation sequencing studies for classic Hodgkin lymphoma: a systematic review","volume":"12","author":"Santisteban-Espejo A","year":"2022","unstructured":"Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, et al.. The need for standardization in next-generation sequencing studies for classic Hodgkin lymphoma: a systematic review. Diagnostics (Basel). 2022, 12:963. 10.3390\/diagnostics12040963","journal-title":"Diagnostics (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina V","year":"2018","unstructured":"Spina V, Bruscaggin A, Cuccaro A, et al.. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood. 2018, 131:2413-25. 10.1182\/blood-2017-11-812073","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000705","article-title":"Concurrent composite lymphomas collectively bearing three diagnostic entities of shared clonal origin","volume":"6","author":"Alduaij W","year":"2022","unstructured":"Alduaij W, Hilton LK, Al Moosawi M, et al.. Concurrent composite lymphomas collectively bearing three diagnostic entities of shared clonal origin. Hemasphere. 2022, 6:e705. 10.1097\/HS9.0000000000000705","journal-title":"Hemasphere"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000858","article-title":"Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma","volume":"134","author":"Wang Y","year":"2019","unstructured":"Wang Y, Link BK, Witzig TE, et al.. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma. Blood. 2019, 134:1289-97. 10.1182\/blood.2019000858","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0450-6","article-title":"Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report","volume":"10","author":"Zhang C","year":"2015","unstructured":"Zhang C, Yi Y, Chen C, Wang J, Liu Z. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report. Diagn Pathol. 2015, 10:215. 10.1186\/s13000-015-0450-6","journal-title":"Diagn Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2021.01.004","article-title":"Role of cell-free DNA in haematological malignancies","volume":"53","author":"Lim JK","year":"2021","unstructured":"Lim JK, Kuss B, Talaulikar D. Role of cell-free DNA in haematological malignancies. Pathology. 2021, 53:416-26. 10.1016\/j.pathol.2021.01.004","journal-title":"Pathology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102106","article-title":"Liquid biopsy in lymphoma: molecular methods and clinical applications","volume":"91","author":"Cirillo M","year":"2020","unstructured":"Cirillo M, Craig AF, Borchmann S, Kurtz DM. Liquid biopsy in lymphoma: molecular methods and clinical applications. Cancer Treat Rev. 2020, 91:102106. 10.1016\/j.ctrv.2020.102106","journal-title":"Cancer Treat Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch AK","year":"2020","unstructured":"Desch AK, Hartung K, Botzen A, et al.. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020, 34:151-66. 10.1038\/s41375-019-0541-6","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253727-occurrence-of-secondary-non-hodgkin-lymphomas-among-our-classical-hodgkin-lymphoma-patients-a-single-centre-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T21:08:55Z","timestamp":1719522535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253727-occurrence-of-secondary-non-hodgkin-lymphomas-among-our-classical-hodgkin-lymphoma-patients-a-single-centre-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.63307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}